更新
4月22日 - ** Teleflex TFX.N股价盘前上涨10%至133.70美元
** 一位消息人士周二称，私募股权公司CVC Capital Partners和GTCR已提交 (link) 一份联合要约，拟将这家医疗设备制造商私有化。
** TFX生产呼吸管、导管和血管通路产品，主要用于医院重症监护室。
** 消息人士称，竞购正在评估中；没有确定的交易，TFX可以拒绝接受竞购，也可以吸引竞争对手的兴趣。
** Teleflex 一直在精简业务，并于 12 月份以 20.3 亿美元的价格出售了三个部门。
** 截至上次收盘，今年股价上涨 ~2%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.